Centers for Disease Control. Table V. Estimated years of potential life lost before age 65 and cause-specific mortality, by cause of death—United States, 1984 . MMWR 1986;35:365.
Centers for Disease Control. Premature mortality in the United States: public health issues in the use of years of potential life lost . MMWR 1986;35(
Sondik EJ, Young JL, Horm JW, Gloeckler Ries LA. 1986 annual cancer statistics review . Bethesda, Maryland: US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, 1987; NIH publication no. 87-2789.
National Cancer Institute. SEER program: cancer incidence and mortality in the United States 1973-81 . Bethesda, Maryland: US Department of Health and Human Services, Public Health Service, National Institutes of Health, 1984; NIH publication no. 85-1837.
Spencer G. Projections of the population of the United States by age, sex, and race: 1983 to 2080 . Washington, DC: US Department of Commerce, Bureau of the Census, 1984. (Current Population Reports; series P-25, no.
Silverberg E, Lubera J. Cancer statistics, 1987 . CA 1987;37:2-19.
Nemoto T, Vana J, Bedwani RN, Baker HW, McGregor FH, Murphy GP. Management and survival of female breast cancer: results of a national survey by the American College of Surgeons . Cancer
1980;45:2917-24.Link to Article
Bassett MT, Krieger N. Social class and blackwhite differences in breast cancer survival . AJPH
1986;76:1400-3.Link to Article
American Cancer Society. Mammography: two statements of the American Cancer Society . New York: American Cancer Society Professional Education Publications, 1983.
National Cancer Institute. Cancer control objectives for the nation: 1985-2000 . Bethesda, Maryland: US Department of Health and Human Services, Public Health Service, National Institutes of Health, 1986; DHHS publication no. (NIH)86-2880. (NCI monograph no. 2).
Howard J. Using mammography for cancer control: an unrealized potential . CA 1987;37:33-48.
Seidman H, Gelb SK, Silverberg E, LaVerda N, Lubera JA. Survival experience in the breast cancer detection demonstration project . CA 1987;37:258-90.
YPLL and YPLL rates were calculated according to standard methods cited in MMWR Supplement, No. 2S, Vol. 35, entitled Premature Mortality in the United States. Mortality figures were for U.S. residents and were obtained from the final mortality tape for 1984 from the National Center for Health Statistics.
Five-year relative survival rates are 96% for patients with cancers detected at Stage I (less than 2 cm, nodes negative) and 50% for those with cancers detected at Stage III (greater than 2cm, nodes positive).3